Most of A&D Medical’s catalogue was suppressed on Amazon. Once the compliance cases were cleared, market share in the US and Canada grew 130%.
A&D Medical: How We Grew Amazon Market Share by 130% Across the US and Canada
The Challenge
A&D Medical is a globally established blood pressure monitor brand with a presence across retail and online channels worldwide. On Amazon, though, persistent compliance issues were holding it back. Most of the catalogue was suppressed, which blocked new product launches and made sustained growth impossible. The brief was to resolve every outstanding compliance issue across Amazon US and Canada, then drive growth in each market: build US market share from scratch, with no products ranked in the top 100, while expanding on an existing number 2 position in Canada.
The Approach
We used our Amazon case management expertise to resolve 102 long-standing suppression cases, and set up an ongoing process to catch new issues quickly, before they could pile up again. Every listing was optimised for discoverability and conversion, from the copy to the imagery to the A+ content. We restructured the advertising campaigns for efficiency and sustainable scale, and backed them with a stock management process to avoid both outages and overstocking.
The Impact
-
59%
Growth in sales revenue across the US and Canada in FY25.
-
130%
Growth in market share across the US and Canada in FY25.
-
102
Long-standing compliance cases resolved in FY26.
The Outcome
In FY25, A&D Medical grew sales revenue by 59% across the US and Canada, and market share by 130%. In the US, where the brand started with nothing in the top 100, its best product now ranks number 17 in its category, up from a previous best of number 63. With the suppressions cleared and a process in place to stop them coming back, the catalogue is finally free to launch and grow.
You May Also Like
